These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 17122127)

  • 1. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
    Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions.
    Sugita S; Futagami Y; Horie S; Mochizuki M
    Exp Eye Res; 2007 Nov; 85(5):626-36. PubMed ID: 17720157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of bystander T helper 1 cells by iris pigment epithelium-inducing regulatory T cells via negative costimulatory signals.
    Sugita S; Horie S; Yamada Y; Keino H; Usui Y; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2529-36. PubMed ID: 19959639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation.
    Sugita S; Ng TF; Schwartzkopff J; Streilein JW
    J Immunol; 2004 Apr; 172(7):4184-94. PubMed ID: 15034031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells.
    Yoshida M; Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells.
    Sugita S; Ng TF; Lucas PJ; Gress RE; Streilein JW
    J Immunol; 2006 Jan; 176(1):118-27. PubMed ID: 16365402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
    Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human iris pigment epithelium suppresses activation of bystander T cells via TGFbeta-TGFbeta receptor interaction.
    Horie S; Sugita S; Futagami Y; Kawaguchi T; Kamoi K; Shirato S; Mochizuki M
    Exp Eye Res; 2009 Jun; 88(6):1033-42. PubMed ID: 19450450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
    Razmara M; Hilliard B; Ziarani AK; Chen YH; Tykocinski ML
    Int Immunol; 2008 Apr; 20(4):471-83. PubMed ID: 18272926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.
    Sugita S; Streilein JW
    J Exp Med; 2003 Jul; 198(1):161-71. PubMed ID: 12835481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
    J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 control over Foxp3+ regulatory T cell function.
    Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
    Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
    Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
    Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells modulate postischemic neovascularization.
    Zouggari Y; Ait-Oufella H; Waeckel L; Vilar J; Loinard C; Cochain C; Récalde A; Duriez M; Levy BI; Lutgens E; Mallat Z; Silvestre JS
    Circulation; 2009 Oct; 120(14):1415-25. PubMed ID: 19770391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
    Mangsbo SM; Sandin LC; Anger K; Korman AJ; Loskog A; Tötterman TH
    J Immunother; 2010 Apr; 33(3):225-35. PubMed ID: 20445343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4.
    Kataoka H; Takahashi S; Takase K; Yamasaki S; Yokosuka T; Koike T; Saito T
    Int Immunol; 2005 Apr; 17(4):421-7. PubMed ID: 15724061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.